1. Age‐Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver. Issue 2 (August 2015) Authors: Burgess, KS; Philips, S; Benson, EA; Desta, Z; Gaedigk, A; Gaedigk, R; Segar, MW; Liu, Y; Skaar, TC Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 2(2015:Aug.) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Issue 2 (29th June 2015) Authors: Hicks, JK; Bishop, JR; Sangkuhl, K; Müller, DJ; Ji, Y; Leckband, SG; Leeder, JS; Graham, RL; Chiulli, DL; LLerena, A; Skaar, TC; Scott, SA; Stingl, JC; Klein, TE; Caudle, KE; Gaedigk, A Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 2(2015:Aug.) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron. Issue 2 (6th April 2017) Authors: Bell, GC; Caudle, KE; Whirl‐Carrillo, M; Gordon, RJ; Hikino, K; Prows, CA; Gaedigk, A; Agundez, JAG; Sadhasivam, S; Klein, TE; Schwab, M Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 2(2017) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Issue 1 (13th February 2017) Authors: Hicks, JK; Sangkuhl, K; Swen, JJ; Ellingrod, VL; Müller, DJ; Shimoda, K; Bishop, JR; Kharasch, ED; Skaar, TC; Gaedigk, A; Dunnenberger, HM; Klein, TE; Caudle, KE; Stingl, JC Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 1(2017) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants. Issue 5 (16th January 2013) Authors: Hicks, J K; Swen, J J; Thorn, C F; Sangkuhl, K; Kharasch, E D; Ellingrod, V L; Skaar, T C; Müller, D J; Gaedigk, A; Stingl, J C Journal: Clinical pharmacology & therapeutics Issue: Volume 93:Issue 5(2013) Page Start: 402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update. Issue 4 (23rd January 2014) Authors: Crews, K R; Gaedigk, A; Dunnenberger, H M; Leeder, J S; Klein, T E; Caudle, K E; Haidar, C E; Shen, D D; Callaghan, J T; Sadhasivam, S; Prows, C A; Kharasch, E D; Skaar, T C Journal: Clinical pharmacology & therapeutics Issue: Volume 95:Issue 4(2014) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ontogeny of Hepatic Drug Transporters as Quantified by LC‐MS/MS Proteomics. Issue 4 (13th August 2016) Authors: Prasad, B; Gaedigk, A; Vrana, M; Gaedigk, R; Leeder, JS; Salphati, L; Chu, X; Xiao, G; Hop, CECA; Evers, R; Gan, L; Unadkat, JD Journal: Clinical pharmacology & therapeutics Issue: Volume 100:Issue 4(2016:Oct.) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting. Issue 2 (20th November 2015) Authors: Kalman, LV; Agúndez, JAG; Appell, M Lindqvist; Black, JL; Bell, GC; Boukouvala, S; Bruckner, C; Bruford, E; Caudle, K; Coulthard, SA; Daly, AK; Tredici, AL Del; den Dunnen, JT; Drozda, K; Everts, RE; Flockhart, D; Freimuth, RR; Gaedigk, A; Hachad, H; Hartshorne, T Journal: Clinical pharmacology & therapeutics Issue: Volume 99:Issue 2(2016:Feb.) Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure. (August 2013) Authors: Sutter, M. E.; Gaedigk, A; Albertson, T. E.; Southard, J.; Owen, K. P.; Mills, L. D.; Diercks, D. B. Journal: Clinical toxicology Issue: Volume 51:Number 7(2013) Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Single dose, CYP2D6 genotype‐stratified pharmacokinetic study of atomoxetine in children with ADHD. Issue 6 (12th January 2016) Authors: Brown, JT; Abdel‐Rahman, SM; van Haandel, L; Gaedigk, A; Lin, YS; Leeder, JS Journal: Clinical pharmacology & therapeutics Issue: Volume 99:Issue 6(2016:Jun.) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗